Randomized Trial Assessing the Effectiveness of a Pharmacist-Delivered Program for Smoking Cessation
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 101
- 试验地点
- 1
- 主要终点
- The primary outcome variable for the study was biochemically verified 7-day point prevalence smoking cessation at 6 months, defined as having smoked no cigarettes - not even a puff - for the previous 7 days.
研究概览
简要总结
This randomized trial compared the effectiveness of a three session pharmacist-delivered group program for smoking versus one 5 to 10 minute standard care session delivered over the telephone on 7-day point prevalence quit rates. Participants in both groups were offered their choice of bupropion IR or nicotine patch at no cost. At 6 months after the established quit date, self-reported cessation was biochemically verified using tests for urinary cotinine.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Smoked one or more cigarettes daily for 7 days
- •Somewhat ready to quit in the next 2 weeks (4 or more on a 10- point scale)
- •Willing and capable of attending three scheduled sessions at the clinic
- •Interested in participating in the study
排除标准
- •Planned to leave the area in the next 6 months
- •Used pharmacotherapy for smoking cessation in the last 30 days
- •Used other forms of tobacco in the last 30 days
- •Schizophrenia
- •Prior participation
研究组 & 干预措施
1
Pharmacist-delivered group program for smoking cession.
干预措施: Pharmacist-delivered group program for smoking cessation (Other)
2
Brief standard care session for tobacco smoking cessation delivered over the telephone.
干预措施: Brief standard care session for smoking cessation delivered over the telephone (Other)
结局指标
主要结局
The primary outcome variable for the study was biochemically verified 7-day point prevalence smoking cessation at 6 months, defined as having smoked no cigarettes - not even a puff - for the previous 7 days.
时间窗: 6 months
次要结局
- Secondary outcomes included 30-day point prevalence abstinence and prolonged abstinence (>6 months).(6 months)